Literature DB >> 18031314

Insulin, adiponectin, IGFBP-1 levels and body composition in small for gestational age born non-obese children during prepubertal ages.

Ozlem Sancakli1, Feyza Darendeliler, Firdevs Bas, Gulbin Gokcay, Rian Disci, Semih Aki, Nurten Eskiyurt.   

Abstract

BACKGROUND: Being small for gestational age (SGA) at birth and postnatal growth pattern may have an impact on insulin resistance and body composition in later life. Adiponectin is a strong determinant of insulin sensitivity.
OBJECTIVE: The aim of this study was to evaluate insulin resistance and adiponectin levels in SGA born children with catch-up growth (CUG) in the absence of obesity in prepubertal ages and relations with body composition and insulin-like growth factor binding protein (IGFBP)-1.
METHODS: Twenty-four (15F, 9M) SGA born children with CUG but without obesity were evaluated at age 6.3 +/- 0.5 years with respect to glucose, insulin, IGFBP-1, leptin and adiponectin levels, and body composition by dual-energy X-ray absorptiometry (DEXA). Their data were compared to that of 62 (27F, 35M) appropriate for gestational age (AGA) children.
RESULTS: SGA and AGA children had similar height standard deviation score (SDS) corrected for parental height and body mass index (BMI) SDS. Homeostasis model for insulin resistance (HOMA-IR) was significantly high in SGA (0.7 +/- 0.6) than in AGA children (0.4 +/- 0.2) (P = 0.029). There were no significant differences in leptin, IGFBP-1, adiponectin, and total and truncal fat between SGA and AGA children. However, being born SGA and having higher BMI in the upper half for the distribution in the sample, although within normal ranges, was associated with lower adiponectin levels (estimated means of log adiponectin levels 3.8 +/- 0.3 vs. 4.4 +/- 0.1 microg/ml, P = 0.040).
CONCLUSIONS: SGA children with CUG and with no obesity have higher insulin levels compared to AGA children. Both SGA birth and recent size seem to have an effect on serum adiponectin levels in childhood.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18031314     DOI: 10.1111/j.1365-2265.2007.03138.x

Source DB:  PubMed          Journal:  Clin Endocrinol (Oxf)        ISSN: 0300-0664            Impact factor:   3.478


  7 in total

Review 1.  Fetal origins of adult disease.

Authors:  Kara Calkins; Sherin U Devaskar
Journal:  Curr Probl Pediatr Adolesc Health Care       Date:  2011-07

2.  Association between height and weight catch-up growth with insulin resistance in pre-pubertal Chinese children born small for gestational age at two different ages.

Authors:  Hong-Zhu Deng; Yan-Hong Li; Zhe Su; Hua-Mei Ma; Yue-Fang Huang; Hong-Shan Chen; Min-Lian Du
Journal:  Eur J Pediatr       Date:  2010-08-24       Impact factor: 3.183

3.  Infant obesity and severe obesity growth patterns in the first two years of life.

Authors:  Lisaann S Gittner; Susan M Ludington-Hoe; Harold S Haller
Journal:  Matern Child Health J       Date:  2014-04

Review 4.  The Role of Fetal, Infant, and Childhood Nutrition in the Timing of Sexual Maturation.

Authors:  Valeria Calcaterra; Hellas Cena; Corrado Regalbuto; Federica Vinci; Debora Porri; Elvira Verduci; Mameli Chiara; Gian Vincenzo Zuccotti
Journal:  Nutrients       Date:  2021-01-28       Impact factor: 5.717

Review 5.  Fetal programming of the neuroendocrine-immune system and metabolic disease.

Authors:  R E Fisher; M Steele; N A Karrow
Journal:  J Pregnancy       Date:  2012-08-16

6.  Insulin resistance and adiponectin levels are associated with height catch-up growth in pre-pubertal Chinese individuals born small for gestational age.

Authors:  Hong-Zhu Deng; Hong Deng; Zhe Su; Yan-Hong Li; Hua-Mei Ma; Hong-Shan Chen; Min-Lian Du
Journal:  Nutr Metab (Lond)       Date:  2012-11-28       Impact factor: 4.169

7.  Metabolic programming of obesity by energy restriction during the perinatal period: different outcomes depending on gender and period, type and severity of restriction.

Authors:  Catalina Picó; Mariona Palou; Teresa Priego; Juana Sánchez; Andreu Palou
Journal:  Front Physiol       Date:  2012-11-22       Impact factor: 4.566

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.